Whois & Analysis for ginasthma.org

The Global Initiative for Asthma (GINA) is a medical guidelines organisation which works with public health officials and health care professionals globally to reduce asthma prevalence, morbidity, and mortality.

GINA was launched in 1993 as a collaboration between National Heart, Lung, and Blood Institute, National Institutes of Health, and the World Health Organization.

A disease is a particular abnormal condition, a disorder of a structure or function, that affects part or all of an organism.

The study of disease is called pathology which includes the study of cause.

Disease is often construed as a medical condition associated with specific symptoms and signs.

It may be caused by external factors such as pathogens, or it may be caused by internal dysfunctions particularly of the immune system such as an immunodeficiency, or a hypersensitivity including allergies and autoimmunity.

Public health refers to "the science and art of preventing disease, prolonging life and promoting human health through organized efforts and informed choices of society, organizations, public and private, communities and individuals." It is concerned with threats to health based on population health analysis.

The population in question can be as small as a handful of people, or as large as all the inhabitants of several continents (for instance, in the case of a pandemic).

The dimensions of health can encompass "a state of complete physical, mental and social well-being and not merely the absence of disease or infirmity," as defined by the United Nations' World Health Organization.

Public health incorporates the interdisciplinary approaches of epidemiology, biostatistics and health services.

Environmental health, community health, behavioral health, health economics, public policy, mental health and occupational safety and health are other important subfields.

Prevalence in epidemiology is the proportion of disease found to have been affecting a particular population (typically a disease or a risk factor such as smoking or seat-belt use).

It is arrived at by comparing the number of people found to have the condition with the total number of people studied, and is usually expressed as a fraction, as a percentage or as the number of cases per 10,000 or 100,000 people.

Point prevalence is the proportion of a population that has the condition at a specific point in time.

Period prevalence is the proportion of a population that has the condition at some time during a given period (e.g., 12 month prevalence), and includes people who already have the condition at the start of the study period as well as those who acquire it during that period.

Lifetime prevalence (LTP) is the proportion of a population that at some point in their life (up to the time of assessment) have experienced the condition.

Mortality rate, or death rate, is a measure of the number of deaths (in general, or due to a specific cause) in a particular population, scaled to the size of that population, per unit of time.

Mortality rate is typically expressed in units of deaths per 1,000 individuals per year; thus, a mortality rate of 9.5 (out of 1,000) in a population of 1,000 would mean 9.5 deaths per year in that entire population, or 0.95% out of the total.

It is distinct from "morbidity", a term used to refer to either the prevalence or incidence of a disease, and also from the incidence rate (the number of newly appearing cases of the disease per unit of time).